Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

HDSN vs ASPN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HDSN Captures Overall Composite Edge (53.2 HOLD vs 46.3 HOLD), While ASPN Leads 4–2 on Growth & Valuation Pillars

HDSN Overall Winner 6-Pillar Tally: HDSN 2 – 4 ASPN Matrix Metrics: HDSN 7 – 3 ASPN

As of Nov 16, 2026, Hudson Technologies Inc (HDSN) captures the overall head-to-head institutional edge over Aspen Aerogels, Inc. (ASPN) on higher Unified Composite conviction (53.2/100 HOLD vs. 46.3/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Profitability & Quality), while ASPN wins 4–2 across the 6-pillar growth and valuation breakdown. HDSN trades at $4.25 (25.9x Forward P/E, 2.0% operating margin) versus ASPN at $5.14 (N/M Forward P/E, -22.2% operating margin).

  • Growth vs. Quality Trade-Off: HDSN earns the overall head-to-head edge with a stronger Unified Composite Score (53.2/100 HOLD vs. ASPN 46.3/100 HOLD) and 1.32β · 68% Vol risk profile, whereas ASPN leads top-line expansion (+16.7% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: HDSN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9); meanwhile ASPN trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 46.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About HDSN vs ASPN
HDSN NASDAQ Head-to-Head Winner
Hudson Technologies Inc
Wholesale-Machinery, Equipment & Supplies
$4.25
-3.52% 1D
Market Cap $186.5M
TTM Revenue $242M
Forward P/E 25.9x
Beta / 30D Vol 1.32β · 68% Vol
Unified Composite Score
53.2 / 100 HOLD
Tech 67.0 Fund 65.0 Flow 55.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -6.3%), weak momentum, RSI 35
RSI-14: 34.9 · SMA20: $4.68 · SMA50: $4.99
ASPN NYSE
Aspen Aerogels, Inc.
Wholesale-Lumber & Other Construction Materials
$5.14
-7.8% 1D
Market Cap $456.0M
TTM Revenue $214M
Forward P/E N/M
Beta / 30D Vol 1.97β · 124% Vol
Unified Composite Score
46.3 / 100 HOLD
Tech 28.0 Fund 43.0 Flow 58.0 Mom 56.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 46.4 · SMA20: $5.40 · SMA50: $5.34

6-Pillar Scorecard Institutional Category Breakdown (HDSN 2 – 4 ASPN)

Columns: Metric · HDSN · ASPN
1. Valuation Multiples HDSN
Forward P/E 25.9x N/M
Trailing P/E 16.5x N/M
PEG Ratio 0.29x N/M
EV / Revenue 0.6x 2.0x
2. Growth & Scale ASPN
Revenue Growth (YoY) -19.7% +16.7%
Earnings Growth (YoY) -82.0% +0.0%
TTM Revenue (USD) $242M $214M
Market Cap $186.5M $456.0M
3. Profitability & Quality HDSN
Gross Margin 21.0% 22.3%
Operating Margin 2.0% -22.2%
Net Profit Margin -0.5% -60.8%
Return on Equity (ROE) -0.5% -53.2%
4. Balance Sheet & Cash Flow ASPN
Cash Generation (TTM) -$32M $20M
Cash Flow Margin -13.0% 9.3%
Net Cash / Leverage $31M Net Cash $30M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ASPN
Options Structure Phase BREAKDOWN CONSOLIDATION
Current IV / %ile 79.1% (15th %ile) 41.1% (<1st %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase ACCUMULATION · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat ASPN
OpEx & R&D Intensity 19.0% of Rev ($46M) 44.5% of Rev ($95M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Specialty Chemicals Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: HDSN (7) vs ASPN (3)
Institutional Metric HDSN ASPN Criterion Row Edge
Market Capitalization
Scale
$186.5M $456.0M Larger Scale ASPN
Trailing P/E Ratio
Valuation
16.5x N/M Lower Multiple HDSN
Forward P/E Ratio
Valuation
25.9x N/M Lower Multiple HDSN
Revenue Growth (YoY)
Growth
-19.7% +16.7% Higher Growth ASPN
Operating Margin (TTM)
Profitability
2.0% -22.2% Higher Margin HDSN
Net Profit Margin
Profitability
-0.5% -60.8% Higher Margin HDSN
Return on Equity (ROE)
Capital Efficiency
-0.5% -53.2% Higher ROE HDSN
52-Week Range Position
Momentum
6% ($4–$8) 49% ($2–$8) Stronger Trend ASPN
Beta / 30D Volatility
Risk Regime
1.32β · 68% Vol 1.97β · 124% Vol Lower Realized Risk HDSN
Unified Institutional Score
Composite Signal
53.2 / 100 (HOLD) 46.3 / 100 (HOLD) Higher Composite HDSN
Trailing 12M Revenue (USD)
Operating Scale
$242M $214M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
21.0% 22.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.29x PEG · 0.6x EV/Rev N/M PEG · 2.0x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$32M ($31M Net Cash) $20M ($30M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ASPN +14.4 pp
HDSN: -15.27% · ASPN: -0.87%
3M Horizon ASPN +16.87 pp
HDSN: -24.67% · ASPN: -7.8%
6M Horizon ASPN +10.77 pp
HDSN: -14.24% · ASPN: -3.47%
1Y Horizon ASPN +97.9 pp
HDSN: -38.12% · ASPN: +59.78%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period HDSN Revenue ASPN Revenue HDSN Op. Margin ASPN Op. Margin Margin Leader
FY2018 $170M $100M -25.6% -32.5% HDSN
FY2019 $160M $140M -9.7% -10.2% HDSN
FY2020 $150M $100M 4.0% -21.5% HDSN
FY2021 $190M $120M 21.9% -33.4% HDSN
FY2022 $330M $180M 40.4% -43.9% HDSN
FY2023 $290M $240M 27.0% -20.6% HDSN
FY2024 $240M $450M 12.4% 12.0% HDSN
FY2025 $250M $270M 7.5% -139.5% HDSN

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
HDSN BREAKDOWN
90d in phase · OBV ACCUMULATION
Current IV 79.1%
IV Percentile 15th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact HDSN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ASPN CONSOLIDATION
118d in phase · OBV NEUTRAL
Current IV 41.1%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ASPN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
HDSN Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $186.5M market capitalization and 2.0% operating margin.
OpEx & R&D Reinvestment 19.0% of Rev ($46M)
90D Engineering Disclosures 0 Published
ASPN Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $456.0M market capitalization and -22.2% operating margin.
OpEx & R&D Reinvestment 44.5% of Rev ($95M)
90D Engineering Disclosures 0 Published

Investor FAQ HDSN vs ASPN Key Questions & Quantitative Answers

As of Nov 16, 2026, Hudson Technologies Inc (HDSN) captures the overall head-to-head institutional edge over Aspen Aerogels, Inc. (ASPN) on higher Unified Composite conviction (53.2/100 HOLD vs. 46.3/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Profitability & Quality), while ASPN wins 4–2 across the 6-pillar growth and valuation breakdown. HDSN trades at $4.25 (25.9x Forward P/E, 2.0% operating margin) versus ASPN at $5.14 (N/M Forward P/E, -22.2% operating margin). Growth vs. Quality Trade-Off: HDSN earns the overall head-to-head edge with a stronger Unified Composite Score (53.2/100 HOLD vs. ASPN 46.3/100 HOLD) and 1.32β · 68% Vol risk profile, whereas ASPN leads top-line expansion (+16.7% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: HDSN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9); meanwhile ASPN trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 46.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ASPN leads the Growth & Scale pillar: HDSN posts -19.7% YoY revenue growth and -82.0% YoY earnings growth on $242M TTM revenue (21.0% gross margin, 2.0% operating margin), compared with ASPN at +16.7% YoY revenue growth and +0.0% YoY earnings growth on $214M TTM revenue (22.3% gross margin, -22.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), HDSN cumulative revenue shifted +47.1% while ASPN shifted +170.0%. In operating R&D and SG&A reinvestment, HDSN deploys 19.0% of Rev ($46M) (0 90-day corporate R&D disclosures) versus 44.5% of Rev ($95M) (0 disclosures) for ASPN.

HDSN screens cheaper on headline valuation multiples. HDSN trades at 25.9x Forward P/E, 16.5x Trailing P/E, 0.29x PEG, and 0.6x EV/Revenue (-13.0% FCF margin), whereas ASPN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 2.0x EV/Revenue (9.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HDSN (-0.5% ROE) versus ASPN (-53.2% ROE) capital efficiency.

In options market volatility and institutional positioning, HDSN carries 79.1% implied volatility (15th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.32β · 68% Vol realized risk). By comparison, ASPN carries 41.1% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.97β · 124% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.